CONTROL BIONICS LIMITED
ASX:CBLHealth Care Equipment & ServicesToday’s holders own 95.6% of what they think they own, once every option and right converts.
Share count grew 120% in 24 months; 4 cash raises in 24 months; runway 4–8 quarters
CONTROL BIONICS LIMITED's ordinary share count grew 119.8% between October 2024 and October 2026, its latest share-count filing, to 544M shares. The company raised capital four times in that period for total disclosed proceeds of A$17.2M, most recently a A$10.0M placement in June 2026. Options and rights on issue could convert into 25M new shares, equal to 4.6% of the current share count, of which 2% are in the money at the current share price; the nearest expiry falls in May 2027. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.
Quick answers · 5
When did CBL last raise capital?
The last capital raise in Control Bionics's filings is Placement of $10.0M announced 25 June 2026, one of 4 cash raises in 24 months.
How much placement capacity does CBL have left?
About 42% of the 15% placement capacity left, about 58% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does CBL have?
In its quarterly cash report for the quarter ended 30 June 2026, Control Bionics reported $2.1M of cash and estimated 1.3 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do CBL's options expire?
Unexercised options and rights equal 4.6% of Control Bionics's shares on issue; the nearest expiry is May 2027.
How much has CBL's share count grown?
Control Bionics has 544.1M shares on issue as at 28 Oct 2026, up 119.8% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 19 Oct 2026 | 2A · quoted issue | CBL : ORDINARY FULLY PAID | 544.1M | Appendix 2A |
| 15 Oct 2026 | 3G · unquoted | CBL : ORDINARY FULLY PAID | 543.1M | Appendix 3G |
| 12 Oct 2026 | 3H · cancellation | CBL : ORDINARY FULLY PAID | 543.1M | Appendix 3H |
| 7 Sept 2026 | 3G · unquoted | CBL : ORDINARY FULLY PAID | 543.1M | Appendix 3G |
| 12 Aug 2026 | 2A · quoted issue | CBL : ORDINARY FULLY PAID | 543.1M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
4 cash raises in the last 24 months · 2 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.049 today, 10.5M securities are in the money (1.9% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 13.5M (2.5% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| CBLAR | Options | Price-triggered | $0.10 | 20 May 2027 | 500k | Filing |
| CBLAH | Options | Price-triggered | $0.22 | 8 Sept 2027 | 366k | Filing |
| CBLAW | Options | Price-triggered | $0.10 | 20 Dec 2027 | 650k | Filing |
| CBLAI | Options | Price-triggered | $0.16 | 19 Jan 2028 | 2.0M | Filing |
| CBLAK | Options | Price-triggered | $0.095 | 10 Aug 2028 | 724k | Filing |
| CBLAL | Options | Price-triggered | $0.095 | 11 Oct 2028 | 316k | Filing |
| CBLAQ | Options | Price-triggered | $0.045 | 13 May 2029 | 500k | Filing |
| CBLAS | Options | Price-triggered | $0.053 | 14 Aug 2029 | 1.0M | Filing |
| CBLAV | Options | Price-triggered | $0.053 | 10 Oct 2029 | 1.7M | Filing |
| CBLAZ | Options | Price-triggered | $0.045 | 25 Aug 2030 | 2.0M | Filing |
| CBLAD | Options | Price-triggered | $0.075 | 7 Sept 2030 | 1.6M | Filing |
| CBLAY | Options | Price-triggered | $0.045 | 26 Nov 2030 | 8.0M | Filing |
| CBLAA | Options | Price-triggered | $0.060 | 1 June 2031 | 250k | Filing |
| CBLAC | Options | Price-triggered | $0.075 | 28 July 2031 | 2.3M | Filing |
| CBLAB | Options | Price-triggered | $0.063 | 13 Aug 2031 | 1.3M | Filing |
| CBLAE | Options | Price-triggered | $0.075 | 15 Oct 2031 | 1.8M | Filing |
1.8M granted 15 Oct 2026: conditions on continued service. Terms | ||||||
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A line under a class is a grant of rights into it, as read from the company’s own filings: its size, any share-price or market-cap hurdles, and the other kinds of condition it carries. A grant is often only part of the class, so its terms say nothing about the rest. Whether a hurdle has been met is not shown.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 19 Oct 2026 | Stephen Rix | Other | 1.0M | — | — | $62k | 3Y notice |
| 15 Oct 2026 | Jeremy Steele | Other | — | 1.8M | — | — | 3Y notice |
| 1 Sept 2026 | Stephen Rix | Buy on-market | 169k | — | — | $10k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.